N-octanoyl dopamine treatment exerts renoprotective properties in acute kidney injury but not in renal allograft recipients

Conclusions NOD treatment reduces renal injury in warm ischaemia, but is not effective in renal transplant in our experimental animal models. The salutary effect of NOD appears to be TPRV1-dependent, not involving large changes in renal perfusion.
Source: Nephrology Dialysis Transplantation - Category: Urology & Nephrology Authors: Tags: BASIC SCIENCE Source Type: research

Related Links:

Source: Journal of Renal Nutrition - Category: Urology & Nephrology Source Type: research
ConclusionRenal carcinomas in non-functional grafts are rare entities and most of them are diagnosed fortuitously. Despite the fact that these tumors are small, low grade and with a good prognosis, regular monitoring of non-functional grafts should be performed with at least an annual ultrasonography.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
Condition:   Kidney Transplantation Intervention:   Other: Educational Video Intervention Sponsor:   State University of New York at Buffalo Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
When it comes to the management of patients with acute kidney injury, how do these two techniques differ, and what are the benefits of each?Nephrology Dialysis Transplantation
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news
Publication date: Available online 24 February 2020Source: The American Journal of SurgeryAuthor(s): Julia Torabi, Athena Konicki, Juan P. Rocca, Maria Ajaimy, Alesa Campbell, Yorg Azzi, Cindy Pynadath, Luz Liriano-Ward, Enver Akalin, Milan Kinkhabwala, Jay A. Graham
Source: The American Journal of Surgery - Category: Surgery Source Type: research
Bone Marrow Transplantation, Published online: 26 February 2020; doi:10.1038/s41409-020-0843-3Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis
Source: Bone Marrow Transplantation - Category: Hematology Authors: Source Type: research
Authors: Thorsteinsdottir H, Salvador CL, Mjøen G, Lie A, Sugulle M, Tøndel C, Brun A, Almaas R, Bjerre A Abstract Growth differentiation factor 15 (GDF-15) is strongly associated with cardiovascular disease (CVD). The aim of our study was to evaluate plasma and urinary levels of GDF-15 after pediatric renal transplantation (Rtx) and in children with chronic kidney disease (CKD) and its associations to cardiovascular risk factors. In this cross-sectional study, GDF-15 was measured in plasma and urine from 53 children with a renal transplant and 83 children with CKD and related to cardiovascular risk f...
Source: Disease Markers - Category: Laboratory Medicine Tags: Dis Markers Source Type: research
Fat accumulation in skeletal muscle was recently established as a major risk factor for cardiovascular disease (CVD) in the general population, but its relevance for patients with kidney failure is unknown. Here we examined the potential association between muscle radiation attenuation (MRA), a non-invasive indicator of fat deposits in muscle, and cardiovascular events in patients with kidney failure treated with peritoneal dialysis (PD) and investigated dynamic changes and determinants of MRA in this population. We retrospectively assessed MRA on computed tomography images collected yearly in 101 incident patients with ki...
Source: Frontiers in Physiology - Category: Physiology Source Type: research
CONCLUSIONS A delayed and extended HMP can recover the graft hemodynamic function, maintain some metabolic activity, and stabilize the accumulated ischemic damage due to a preliminary SCS. PMID: 32094320 [PubMed - in process]
Source: Annals of Transplantation - Category: Transplant Surgery Authors: Tags: Ann Transplant Source Type: research
The United States Public Health Service Flag Promotion ceremony for Rear Admiral (RADM) Richard W. Childs, promoted to RADM Upper Half O-8 in January 2020, is being webcast live on 3/27/2020 from Masur Auditorium. Richard Childs, MD serves as the Clinical Director of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH). He was commissioned in the USPHS Commissioned Corps as a Lieutenant in 1995 when joined the NCI as an Oncology Fellow. Following fellowship training, he was appointed a tenure-track investigator in the Hematology Branch of the NHLBI where he continues to conduct r...
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video
More News: Bone Graft | Brain | Dialysis | Kidney Transplant | Kidney Transplantation | MRI Scan | Neurology | Perfusion | Science | Transplant Surgery | Transplants | Urology & Nephrology